Dynavax Technologies
DVAX
#5493
Rank
C$1.79 B
Marketcap
C$15.27
Share price
-0.09%
Change (1 day)
-15.83%
Change (1 year)

Dynavax Technologies (DVAX) - Total debt

Total debt on the balance sheet as of September 2025 : C$0.39 Billion

According to Dynavax Technologies 's latest financial reports the company's total debt is C$0.39 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dynavax Technologies - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$0.36 B7.14%
2023-12-31C$0.34 B-2.67%
2022-12-31C$0.35 B6.73%
2021-12-31C$0.32 B18.09%
2020-12-31C$0.27 B-1.74%
2019-12-31C$0.28 B105.73%
2018-12-31C$0.13 B
2014-12-31C$11.09 M
2012-12-31N/A-100%
2011-12-31C$13.03 M10.64%
2010-12-31C$11.77 M-9.6%
2009-12-31C$13.02 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Agenus
AGEN
C$63.82 M-83.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$9.18 B 2,212.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$57.69 B 14,415.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$34.77 B 8,650.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$45.50 B 11,348.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
C$33.27 B 8,271.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
C$84.84 B 21,248.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$23.80 B 5,890.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
C$76.11 B 19,051.72%๐Ÿ‡บ๐Ÿ‡ธ USA